Android app on Google Play

Urologix (ULGX) Closes 5.2M Offering, Full-Allotment Exercised

August 7, 2012 1:01 PM EDT Send to a Friend
Get Alerts ULGX Hot Sheet
Trade ULGX Now!
Join SI Premium – FREE
Urologix, Inc. (Nasdaq: ULGX), announced the sale of an additional 780,000 shares of its common stock at a price to the public of $0.75 per share. The sale was pursuant to a 45-day over-allotment option granted to the underwriter as part of the Company's recently completed public offering of 5,200,000 shares of its common stock that closed July 5, 2012. Urologix received proceeds of approximately $544,000, after underwriter discounts, from the sale of the over-allotment shares.

Dougherty & Company LLC served as the sole underwriter for the offering.




You May Also Be Interested In


Related Categories

Corporate News, Equity Offerings

Related Entities

Dougherty & Company

Add Your Comment